{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:11:59Z","timestamp":1787170319637,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["543002001"],"award-info":[{"award-number":["543002001"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["543002001"],"award-info":[{"award-number":["543002001"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["543002001"],"award-info":[{"award-number":["543002001"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["543002001"],"award-info":[{"award-number":["543002001"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["543002001"],"award-info":[{"award-number":["543002001"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pregnant women\u2019s perspectives should be included in the dialogue surrounding the expanding offers of non-invasive prenatal testing (NIPT), especially now that technological possibilities are rapidly increasing. This study evaluated women\u2019s experiences with the offer of genome-wide (GW) first-tier NIPT in a national screening program. A nationwide pre-and post-test questionnaire was completed by 473 pregnant women choosing between targeted NIPT (trisomies 21, 18 and 13 only) and GW-NIPT (also other findings) within the Dutch TRIDENT-2 study. Measures included satisfaction, reasons for or against choosing GW-NIPT, anxiety, and opinion on the future scope of NIPT. Most respondents (90.4%) were glad to have been offered the choice between GW-NIPT and targeted NIPT; 76.5% chose GW-NIPT. Main reasons to choose GW-NIPT were \u2018wanting as much information as possible regarding the child\u2019s health\u2019 (38.6%) and \u2018to be prepared for everything\u2019 (23.8%). Main reasons to choose targeted NIPT were \u2018avoiding uncertain results\/outcomes\u2019 (33.7%) and \u2018not wanting to unnecessarily worry\u2019 (32.6%). Nearly all respondents received a low-risk NIPT result (98.7%). No differences were found in anxiety between women choosing GW-NIPT and targeted NIPT. Most respondents were favorable toward future prenatal screening for a range of conditions, including life-threatening disorders, mental disabilities, disorders treatable in pregnancy and severe physical disabilities, regardless of their choice for GW-NIPT or targeted NIPT. In conclusion, women who chose first-tier NIPT were satisfied with the choice between GW-NIPT and targeted NIPT, and most women were favorable toward a broader future screening offer. Our results contribute to the debate concerning the expansion of NIPT.<\/jats:p>","DOI":"10.1038\/s41431-022-01248-x","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T22:02:33Z","timestamp":1670536953000},"page":"555-561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Experiences of pregnant women with genome-wide non-invasive prenatal testing in a national screening program"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1801-588X","authenticated-orcid":false,"given":"Karuna R. M.","family":"van der Meij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu Ying. F.","family":"van de Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7372-4291","authenticated-orcid":false,"given":"Mireille N.","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3041-6536","authenticated-orcid":false,"given":"Linda","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5742-7246","authenticated-orcid":false,"given":"Janneke","family":"Gitsels-van der Wal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsbeth H.","family":"van Vliet-Lachotzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-1406","authenticated-orcid":false,"given":"Janneke M.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8101-6180","authenticated-orcid":false,"given":"Robert-Jan H.","family":"Galjaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7187-4563","authenticated-orcid":false,"given":"Erik A.","family":"Sistermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1675-2234","authenticated-orcid":false,"given":"Merryn V. E.","family":"Macville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3531-0597","authenticated-orcid":false,"given":"Lidewij","family":"Henneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Dutch NIPT Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karuna R. M.","family":"van der Meij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsbeth H.","family":"van Vliet-Lachotzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"1248_CR1","doi-asserted-by":"publisher","first-page":"231fs15","DOI":"10.1126\/scitranslmed.3008704","volume":"6","author":"S Chandrasekharan","year":"2014","unstructured":"Chandrasekharan S, Minear MA, Hung A, Allyse M. Noninvasive prenatal testing goes global. Sci Transl Med. 2014;6:231fs15.","journal-title":"Sci Transl Med"},{"key":"1248_CR2","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/aogs.13841","volume":"99","author":"K Gadsb\u00f8ll","year":"2020","unstructured":"Gadsb\u00f8ll K, Petersen OB, Gatinois V, Strange H, Jacobsson B, Wapner R, et al. Current use of noninvasive prenatal testing in Europe, Australia and the USA: a graphical presentation. Acta Obstet Gynecol Scand. 2020;99:722\u201330.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1248_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-genom-083118-015053","volume":"22","author":"V Ravitsky","year":"2021","unstructured":"Ravitsky V, Roy MC, Haidar H, Henneman L, Marshall J, Newson AJ, et al. The emergence and global spread of noninvasive prenatal testing. Ann Rev Genom Human Genet. 2021;22:309\u201338.","journal-title":"Ann Rev Genom Human Genet"},{"key":"1248_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrg.2016.97","volume":"17","author":"JR Vermeesch","year":"2016","unstructured":"Vermeesch JR, Voet T, Devriendt K. Prenatal and pre-implantation genetic diagnosis. Nat Rev Genet. 2016;17:643\u201356.","journal-title":"Nat Rev Genet"},{"key":"1248_CR5","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.ajhg.2019.10.005","volume":"105","author":"KRM van der Meij","year":"2019","unstructured":"van der Meij KRM, Sistermans EA, Macville MVE, Stevens SJC, Bax CJ, Bekker MN, et al. TRIDENT-2: National Implementation of Genome-Wide Non-Invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands. Am J Hum Genet. 2019;105:1091\u2013101.","journal-title":"Am J Hum Genet"},{"key":"1248_CR6","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41436-021-01101-4","volume":"23","author":"K Van Den Bogaert","year":"2021","unstructured":"Van Den Bogaert K, Lannoo L, Brison N, Gatinois V, Baetens M, Blaumeiser B, et al. Outcome of publicly funded nationwide first-tier noninvasive prenatal screening. Genet Med. 2021;23:1137\u201342.","journal-title":"Genet Med"},{"key":"1248_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1056\/NEJMra1705345","volume":"379","author":"DW Bianchi","year":"2018","unstructured":"Bianchi DW, Chiu RWK. Sequencing of Circulating Cell-free DNA during Pregnancy. N Engl J Med. 2018;379:464\u201373.","journal-title":"N Engl J Med"},{"key":"1248_CR8","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/pd.5943","volume":"41","author":"L Christiaens","year":"2021","unstructured":"Christiaens L, Chitty LS, Langlois S. Current controversies in prenatal diagnosis: Expanded NIPT that includes conditions otherthan trisomies 13, 18, and 21 should be offered. Prenatal Diagn. 2021;41:1316\u201323.","journal-title":"Prenatal Diagn"},{"key":"1248_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/pd.5216","volume":"38","author":"LS Chitty","year":"2018","unstructured":"Chitty LS, Hudgins L, Norton ME. Current controversies in prenatal diagnosis 2: Cell-free DNA prenatal screening should be used to identify all chromosome abnormalities. Prenat Diagn. 2018;38:160\u20135.","journal-title":"Prenat Diagn"},{"key":"1248_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/uog.22030","volume":"55","author":"M Bekker","year":"2020","unstructured":"Bekker M, Henneman L, Macville M, Sistermans E, Galjaard R-J. Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data. Ultrasound Obstetrics Gynecol. 2020;55:695\u20136.","journal-title":"Ultrasound Obstetrics Gynecol"},{"key":"1248_CR11","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.ajhg.2022.04.018","volume":"109","author":"L van Prooyen Schuurman","year":"2022","unstructured":"van Prooyen Schuurman L, Sistermans EA, Van Opstal D, Henneman L, Bekker MN, Bax CJ, et al. Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study. Am J Human Genet. 2022;109:1140\u201352.","journal-title":"Am J Human Genet"},{"key":"1248_CR12","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1097\/AOG.0000000000004084","volume":"136","author":"NC Rose","year":"2020","unstructured":"Rose NC, Kaimal AJ, Dugoff L, Norton ME. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226. Obstet Gynecol. 2020;136:e48\u2013e69.","journal-title":"Obstet Gynecol"},{"key":"1248_CR13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/pd.4608","volume":"35","author":"P Benn","year":"2015","unstructured":"Benn P, Borrell A, Chiu RW, Cuckle H, Dugoff L, Faas B, et al. Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn. 2015;35:725\u201334.","journal-title":"Prenat Diagn"},{"key":"1248_CR14","unstructured":"Kliff S, Bhatia A. When They Warn of Rare Disorders, These Prenatal Tests Are Usually Wrong. The New York Times. 2022. https:\/\/www.nytimes.com\/2022\/01\/01\/upshot\/pregnancy-birth-genetic-testing.html"},{"key":"1248_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/pd.5207","volume":"38","author":"EKL Chiu","year":"2018","unstructured":"Chiu EKL, Hui WWI, Chiu RWK. cfDNA screening and diagnosis of monogenic disorders - where are we heading? Prenat Diagn. 2018;38:52\u20138.","journal-title":"Prenat Diagn"},{"key":"1248_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22414-6","volume":"8","author":"V Chesnais","year":"2018","unstructured":"Chesnais V, Ott A, Chaplais E, Gabillard S, Pallares D, Vauloup-Fellous C, et al. Using massively parallel shotgun sequencing of maternal plasmatic cell-free DNA for cytomegalovirus DNA detection during pregnancy: a proof of concept study. Sci Rep. 2018;8:4321.","journal-title":"Sci Rep."},{"key":"1248_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79008-4","volume":"10","author":"V Manders","year":"2020","unstructured":"Manders V, Visser A, Keijser R, Min N, Poutsma A, Mulders J, et al. The bivariate NRIP1\/ZEB2 RNA marker permits non-invasive presymptomatic screening of pre-eclampsia. Sci Rep. 2020;10:21857.","journal-title":"Sci Rep"},{"key":"1248_CR18","first-page":"228","volume":"2","author":"J Linthorst","year":"2021","unstructured":"Linthorst J, Welkers MRA, Sistermans EA. Distinct fragmentation patterns of circulating viral cell-free DNA in 83,552 non-invasive prenatal testing samples. Extracellular Vesicles and Circulating. Nucleic Acids. 2021;2:228\u201337.","journal-title":"Nucleic Acids"},{"key":"1248_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-019-2518-x","volume":"19","author":"V Labont\u00e9","year":"2019","unstructured":"Labont\u00e9 V, Alsaid D, Lang B, Meerpohl JJ. Psychological and social consequences of non-invasive prenatal testing (NIPT): a scoping review. BMC Pregnancy Childbirth. 2019;19:385.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1248_CR20","doi-asserted-by":"crossref","unstructured":"Heesterbeek CJ, Aukema SM, Galjaard RH, Boon EMJ, Srebniak MI, Bouman K, et al. Noninvasive Prenatal Test Results Indicative of Maternal Malignancies: A Nationwide Genetic and Clinical Follow-Up Study. J Clin Oncol. 2022:40:2426\u201335.","DOI":"10.1200\/JCO.21.02260"},{"key":"1248_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41431-021-00940-8","volume":"30","author":"KRM van der Meij","year":"2022","unstructured":"van der Meij KRM, Njio A, Martin L, Gitsels-van der Wal JT, Bekker MN, van Vliet-Lachotzki EH, et al. Routinization of prenatal screening with the non-invasive prenatal test: pregnant women\u2019s perspectives. Eur J Human Genet. 2022;30:661\u20138.","journal-title":"Eur J Human Genet"},{"key":"1248_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.2044-8260.1992.tb00997.x","volume":"31","author":"TM Marteau","year":"1992","unstructured":"Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol. 1992;31:301\u20136.","journal-title":"Br J Clin Psychol"},{"key":"1248_CR23","first-page":"84","volume":"6","author":"AK van der Bij","year":"2003","unstructured":"van der Bij AK, de Weerd S, Cikot RJ, Steegers EA, Braspenning JC. Validation of the dutch short form of the state scale of the Spielberger State-Trait Anxiety Inventory: considerations for usage in screening outcomes. Comm Genet. 2003;6:84\u20137.","journal-title":"Comm Genet"},{"key":"1248_CR24","doi-asserted-by":"publisher","first-page":"e013413","DOI":"10.1136\/bmjopen-2016-013413","volume":"7","author":"JM Koelewijn","year":"2017","unstructured":"Koelewijn JM, Sluijs AM, Vrijkotte TGM. Possible relationship between general and pregnancy-related anxiety during the first half of pregnancy and the birth process: a prospective cohort study. BMJ Open. 2017;7:e013413.","journal-title":"BMJ Open"},{"key":"1248_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00737-015-0531-2","volume":"19","author":"AC Huizink","year":"2016","unstructured":"Huizink AC, Delforterie MJ, Scheinin NM, Tolvanen M, Karlsson L, Karlsson H. Adaption of pregnancy anxiety questionnaire\u2013revised for all pregnant women regardless of parity: PRAQ-R2. Arch Women\u2019s Mental Health. 2016;19:125\u201332.","journal-title":"Arch Women\u2019s Mental Health"},{"key":"1248_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.comppsych.2017.02.002","volume":"75","author":"M Westerneng","year":"2017","unstructured":"Westerneng M, Witteveen AB, Warmelink JC, Spelten E, Honig A, de Cock P. Pregnancy-specific anxiety and its association with background characteristics and health-related behaviors in a low-risk population. Comprehen Psychiatry. 2017;75:6\u201313.","journal-title":"Comprehen Psychiatry"},{"key":"1248_CR27","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/pd.4579","volume":"35","author":"RV van Schendel","year":"2015","unstructured":"van Schendel RV, Dondorp WJ, Timmermans DR, van Hugte EJ, de Boer A, Pajkrt E, et al. NIPT-based screening for Down syndrome and beyond: what do pregnant women think? Prenat Diagn. 2015;35:598\u2013604.","journal-title":"Prenat Diagn"},{"key":"1248_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pec.2010.07.037","volume":"84","author":"HM Schoonen","year":"2011","unstructured":"Schoonen HM, van Agt HM, Essink-Bot ML, Wildschut HI, Steegers EA, de Koning HJ. Informed decision-making in prenatal screening for Down\u2019s syndrome: what knowledge is relevant? Patient Educ Couns. 2011;84:265\u201370.","journal-title":"Patient Educ Couns"},{"key":"1248_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.pec.2005.09.007","volume":"63","author":"M van den Berg","year":"2006","unstructured":"van den Berg M, Timmermans DR, ten Kate LP, van Vugt JM, van der Wal G. Informed decision making in the context of prenatal screening. Patient Educ Couns. 2006;63:110\u20137.","journal-title":"Patient Educ Couns"},{"key":"1248_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/cge.12479","volume":"88","author":"SL van der Steen","year":"2014","unstructured":"van der Steen SL, Diderich KEM, Riedijk SR, Verhagen-Visser J, Govaerts LCP, Joosten M, et al. Pregnant couples at increased risk for common aneuploidies choose maximal information from invasive genetic testing. Clin Genet. 2014;88:25\u201331.","journal-title":"Clin Genet"},{"key":"1248_CR31","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/ejhg.2015.249","volume":"24","author":"M Hill","year":"2015","unstructured":"Hill M, Johnson J-A, Langlois S, Lee H, Winsor S, Dineley B, et al. Preferences for prenatal tests for Down syndrome: an international comparison of the views of pregnant women and health professionals. Eur J Hum Genet. 2015;24:968\u201375.","journal-title":"Eur J Hum Genet"},{"key":"1248_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/15265161.2020.1867933","volume":"22","author":"MJ Bayefsky","year":"2022","unstructured":"Bayefsky MJ, Berkman BE. Implementing Expanded Prenatal Genetic Testing: Should Parents Have Access to Any and All Fetal Genetic Information? Am J Bioeth. 2022;22:4\u201322.","journal-title":"Am J Bioeth"},{"key":"1248_CR33","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/pd.4697","volume":"35","author":"S Tamminga","year":"2015","unstructured":"Tamminga S, van Schendel RV, Rommers W, Bilardo CM, Pajkrt E, Dondorp WJ, et al. Changing to NIPT as a first-tier screening test and future perspectives: opinions of health professionals. Prenat Diagn. 2015;35:1316\u201323.","journal-title":"Prenat Diagn"},{"key":"1248_CR34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/jama.2015.7120","volume":"314","author":"DW Bianchi","year":"2015","unstructured":"Bianchi DW, Chudova D, Sehnert AJ, Bhatt S, Murray K, Prosen TL, et al. Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies. JAMA. 2015;314:162\u20139.","journal-title":"JAMA."},{"key":"1248_CR35","unstructured":"Gammon BL, Jaramillo C, Riggan KA, Allyse M. Decisional regret in women receiving high risk or inconclusive prenatal cell-free DNA screening results. J Matern Fetal Neonatal Med. 2020;33:1412\u20138."},{"key":"1248_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/aogs.12482","volume":"94","author":"S Lou","year":"2015","unstructured":"Lou S, Mikkelsen L, Hvidman L, Petersen OB. Nielsen CPj. Does screening for Down\u2019s syndrome cause anxiety in pregnant women? A systematic review. Acta Obstet Gynecol Scand. 2015;94:15\u201327.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1248_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00737-011-0217-3","volume":"14","author":"B Figueiredo","year":"2011","unstructured":"Figueiredo B, Conde A. Anxiety and depression in women and men from early pregnancy to 3-months postpartum. Arch Womens Ment Health. 2011;14:247\u201355.","journal-title":"Arch Womens Ment Health"},{"key":"1248_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/jan.13456","volume":"74","author":"K Evans","year":"2018","unstructured":"Evans K, Morrell CJ, Spiby H. Systematic review and meta-analysis of non-pharmacological interventions to reduce the symptoms of mild to moderate anxiety in pregnant women. J Adv Nurs. 2018;74:289\u2013309.","journal-title":"J Adv Nurs"},{"key":"1248_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00737-018-0936-9","volume":"23","author":"K Evans","year":"2020","unstructured":"Evans K, Spiby H, Morrell JC. Non-pharmacological interventions to reduce the symptoms of mild to moderate anxiety in pregnant women. A systematic review and narrative synthesis of women\u2019s views on the acceptability of and satisfaction with interventions. Arch Women\u2019s Mental Health. 2020;23:11\u201328.","journal-title":"Arch Women\u2019s Mental Health"},{"key":"1248_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-020-03538-y","volume":"21","author":"H Haidar","year":"2021","unstructured":"Haidar H, Le Clerc-Blain J, Vanstone M, Laberge A-M, Bibeau G, Ghulmiyyah L, et al. A qualitative study of women and partners from Lebanon and Quebec regarding an expanded scope of noninvasive prenatal testing. BMC Pregnancy Childbirth. 2021;21:54.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1248_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/medethics-2018-105167","volume":"45","author":"H Bowman-Smart","year":"2019","unstructured":"Bowman-Smart H, Savulescu J, Mand C, Gyngell C, Pertile MD, Lewis S, et al. \u2018Is it better not to know certain things?\u2019: views of women who have undergone non-invasive prenatal testing on its possible future applications. J Med Ethics. 2019;45:231.","journal-title":"J Med Ethics"},{"key":"1248_CR42","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/ejhg.2015.57","volume":"23","author":"W Dondorp","year":"2015","unstructured":"Dondorp W, de Wert G, Bombard Y, Bianchi DW, Bergmann C, Borry P, et al. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet. 2015;23:1438\u201350.","journal-title":"Eur J Hum Genet"},{"key":"1248_CR43","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/bioe.12760","volume":"34","author":"A Kater-Kuipers","year":"2020","unstructured":"Kater-Kuipers A, de Beaufort ID, Galjaard R-JH, Bunnik EM. Rethinking counselling in prenatal screening: An ethical analysis of informed consent in the context of non-invasive prenatal testing (NIPT). Bioethics. 2020;34:671\u20138.","journal-title":"Bioethics."},{"key":"1248_CR44","doi-asserted-by":"crossref","unstructured":"van der Meij KRM Implementing genome-wide non-invasive prenatal testing in a national prenatal screening program. Amsterdam: Vrije Universiteit; 2022. https:\/\/research.vu.nl\/en\/publications\/implementing-genome-wide-non-invasive-prenatal-testing-in-a-natio.","DOI":"10.1002\/pd.6296"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01248-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01248-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01248-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T19:07:45Z","timestamp":1683745665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01248-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1248"],"URL":"https:\/\/doi.org\/10.1038\/s41431-022-01248-x","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"assertion":[{"value":"25 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the VU University Medical Center Amsterdam Ethical committee (VUMC No. 2017.165).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}